{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Sulphonamide", "anticancer activity", "trimethoxyphenyl", "tubulin polymerisation inhibitors"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34157927", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "14"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "14"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2021.1943378"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "36", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Synthesis, biological evaluation and molecular docking investigation of new sulphonamide derivatives bearing naphthalene moiety as potent tubulin polymerisation inhibitors.", "Pagination": {"StartPage": "1402", "EndPage": "1410", "MedlinePgn": "1402-1410"}, "Abstract": {"AbstractText": ["A new series of sulphonamide derivatives bearing naphthalene moiety were synthesised and evaluated for their antiproliferative and tubulin polymerisation inhibitory activities. These new compounds were evaluated for their <i>in\u00a0vitro</i> antiproliferative activity against MCF-7 and A549 by using CCK-8 method. Among all the tested compounds, compound <b>5c</b> with naphthalen-1-yl moiety exhibited the most potent antiproliferative activity against MCF-7 and A549 cell line, with IC<sub>50</sub> values of 0.51\u2009\u00b1\u20090.03\u2009\u00b5M and 0.33\u2009\u00b1\u20090.01\u2009\u00b5M, respectively. The results of tubulin polymerisation assay shown that <b>5c</b> exhibited a significant ability to inhibit tubulin polymerisation with IC<sub>50</sub> value of 2.8\u2009\u03bcM. Consistent with its antitubulin activity, <b>5c</b> can significantly arrest the cell cycle at G2/M phase and induce apoptosis in MCF-7 cancer cells. Molecular docking study indicated that compound <b>5c</b> inhibited tubulin polymerisation through interacting at the colchicine-binding site of tubulin. Furthermore, <b>5c</b> exhibited low cytotoxic activity on human normal cell line."]}, "AuthorList": [{"Identifier": ["0000-0001-9104-337X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}], "LastName": "Wang", "ForeName": "Guangcheng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Fan", "ForeName": "Meiyan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Wenjing", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "He", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, China."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Food Science and Technology, Shanghai Ocean University, Shanghai, China."}], "LastName": "Peng", "ForeName": "Zhiyun", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthalenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfonamides"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "A549 Cells"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Naphthalenes"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Sulfonamides"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Tubulin Modulators"}], "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jordan MA, Wilson L.. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253\u201365.", "ArticleIdList": ["15057285"]}, {"Citation": "Akhmanova A, Steinmetz MO.. Control of microtubule organization and dynamics: two ends in the limelight. Nat Rev Mol Cell Biol 2015;16:711\u201326.", "ArticleIdList": ["26562752"]}, {"Citation": "Janke C. The tubulin code: molecular components, readout mechanisms, and functions. J Cell Biol 2014;206:461\u201372.", "ArticleIdList": ["PMC4137062", "25135932"]}, {"Citation": "Pasquier E, Andr\u00e9 N, Braguer D.. Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment. Curr Cancer Drug Targets 2007;7:566\u201381.", "ArticleIdList": ["17896922"]}, {"Citation": "Dumontet C, Jordan MA.. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 2010;9:790\u2013803.", "ArticleIdList": ["PMC3194401", "20885410"]}, {"Citation": "Haider K, Rahaman S, Yar MS, Kamal A.. Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018). Expert Opin Ther Pat 2019;29:623\u201341.", "ArticleIdList": ["31353978"]}, {"Citation": "Stanton RA, Gernert KM, Nettles JH, Aneja R.. Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev 2011;31:443\u201381.", "ArticleIdList": ["PMC3155728", "21381049"]}, {"Citation": "Mukhtar E, Adhami VM, Mukhtar H.. Targeting microtubules by natural agents for cancer therapy. Mol Cancer Ther 2014;13:275\u201384.", "ArticleIdList": ["PMC3946048", "24435445"]}, {"Citation": "Attard G, Greystoke A, Kaye S, De Bono J.. Update on tubulin-binding agents. Pathol Biol 2006;54:72\u201384.", "ArticleIdList": ["16545633"]}, {"Citation": "Khan FA, Mushtaq S, Naz S, et al. . Sulfonamides as potential bioactive scaffolds. Curr Org Chem 2018;22:818\u201330."}, {"Citation": "Yoshino H, Ueda N, Niijima J, et al. . Novel sulfonamides as potential, systemically active antitumor agents. J Med Chem 1992;35:2496\u20137.", "ArticleIdList": ["1619621"]}, {"Citation": "Tanaka H, Ohshima N, Ikenoya M, et al. . Hmn-176, an active metabolite of the synthetic antitumor agent hmn-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor nf-y. Cancer Res 2003;63:6942\u20137.", "ArticleIdList": ["14583495"]}, {"Citation": "Lee HY, Pan SL, Su MC, et al. . Furanylazaindoles: potent anticancer agents in\u00a0vitro and in\u00a0vivo. J Med Chem 2013;56:8008\u201318.", "ArticleIdList": ["24106982"]}, {"Citation": "Chang JY, Hsieh HP, Chang CY, et al. . 7-aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents. J Med Chem 2006;49:6656\u20139.", "ArticleIdList": ["17154496"]}, {"Citation": "Jian S, Gao QL, Wu BW, et al. . Novel tertiary sulfonamide derivatives containing benzimidazole moiety as potent anti-gastric cancer agents: design, synthesis and sar studies. Eur J Med Chem 2019;183:111731.", "ArticleIdList": ["31577977"]}, {"Citation": "Li L, Jiang SB, Li XX, et al. . Recent advances in trimethoxyphenyl (tmp) based tubulin inhibitors targeting the colchicine binding site. Eur J Med Chem 2018;151:482\u201394.", "ArticleIdList": ["29649743"]}, {"Citation": "Rischin D, Bibby DC, Chong G, et al. . Clinical, pharmacodynamic, and pharmacokinetic evaluation of bnc105p: a phase i trial of a novel vascular disrupting agent and inhibitor of cancer cell proliferation. Clin Cancer Res 2011;17:5152\u201360.", "ArticleIdList": ["21690571"]}, {"Citation": "Kirwan IG, Loadman PM, Swaine DJ, et al. . Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin a4 phosphate and a1 phosphate. Clin Cancer Res 2004;10:1446\u201353.", "ArticleIdList": ["14977848"]}, {"Citation": "Lee J, Bae S, Lee SH, et al. . Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog. Bioorg Med Chem Lett 2010;20:6327\u201330.", "ArticleIdList": ["20850313"]}, {"Citation": "von Pawel J, DISRUPT Investigators, Gorbounova V, Reck M, et al. . Disrupt: a randomised phase 2 trial of ombrabulin (ave8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer. Lung Cancer 2014;85:224\u20139.", "ArticleIdList": ["24888230"]}, {"Citation": "Wang G, Liu W, Gong Z, et al. . Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on mcf-7 breast cancer cells by targeting tubulin colchicine binding site. J Enzyme Inhib Med Chem 2020;35:139\u201344.", "ArticleIdList": ["PMC6882462", "31724435"]}, {"Citation": "Wang G, Liu W, Gong Z, et al. . Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors. Bioorg Chem 2020;95:103565.", "ArticleIdList": ["31927336"]}, {"Citation": "Wang G, Liu W, Peng Z, et al. . Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on mcf-7 breast cancer cells by inhibiting tubulin polymerization. Bioorg Chem 2020;103:104141.", "ArticleIdList": ["32750611"]}, {"Citation": "Wang G, Liu W, Tang J, et al. . Design, synthesis, and anticancer evaluation of benzophenone derivatives bearing naphthalene moiety as novel tubulin polymerization inhibitors. Bioorg Chem 2020;104:104265.", "ArticleIdList": ["32919128"]}, {"Citation": "Viegas-Junior C, Danuello A, VdS B, et al. . Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem 2007;14:1829\u201352.", "ArticleIdList": ["17627520"]}, {"Citation": "Wang XD, Wei W, Wang PF, et al. . Novel 3-arylfuran-2(5h)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent. Bioorg Med Chem 2014;22:3620\u20138.", "ArticleIdList": ["24882676"]}, {"Citation": "Xiao ZP, Peng ZY, Dong JJ, et al. . Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as helicobacter pylori urease inhibitors. Eur J Med Chem 2013;63:685\u201395.", "ArticleIdList": ["23567958"]}, {"Citation": "Wang G, Qiu J, Xiao X, et al. . Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents. Bioorg Chem 2018;76:249\u201357.", "ArticleIdList": ["29197743"]}, {"Citation": "Ji YT, Liu YN, Liu ZP.. Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments. Curr Med Chem 2015;22:1348\u201360.", "ArticleIdList": ["25620094"]}, {"Citation": "Mustafa M, Anwar S, Elgamal F, et al. . Potent combretastatin a-4 analogs containing 1,2,4-triazole: synthesis, antiproliferative, anti-tubulin activity, and docking study. Eur J Med Chem 2019;183:111697.", "ArticleIdList": ["31536891"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "23", "Hour": "5", "Minute": "39"}, {"Year": "2021", "Month": "6", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34157927", "PMC8231400", "10.1080/14756366.2021.1943378"]}}], "PubmedBookArticle": []}